Precision Biosciences (DTIL) Receivables - Net (2018 - 2025)
Precision Biosciences (DTIL) has disclosed Receivables - Net for 8 consecutive years, with $4000.0 as the latest value for Q3 2025.
- Quarterly Receivables - Net fell 97.87% to $4000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4000.0 through Sep 2025, down 97.87% year-over-year, with the annual reading at $229000.0 for FY2024, 74.58% down from the prior year.
- Receivables - Net for Q3 2025 was $4000.0 at Precision Biosciences, roughly flat from $4000.0 in the prior quarter.
- The five-year high for Receivables - Net was $50.5 million in Q2 2022, with the low at $4000.0 in Q1 2025.
- Average Receivables - Net over 5 years is $4.4 million, with a median of $488000.0 recorded in 2021.
- The sharpest move saw Receivables - Net skyrocketed 10249.8% in 2022, then plummeted 98.97% in 2025.
- Over 5 years, Receivables - Net stood at $488000.0 in 2021, then surged by 47.54% to $720000.0 in 2022, then rose by 25.14% to $901000.0 in 2023, then tumbled by 74.58% to $229000.0 in 2024, then tumbled by 98.25% to $4000.0 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $4000.0, $4000.0, and $229000.0 for Q3 2025, Q1 2025, and Q4 2024 respectively.